Latigobio
We are seeking an experienced and execution-oriented Associate Director / Director, Drug Product Development to lead drug product activities for small-molecule programs from candidate selection through clinical development, registration, and commercialization. This individual will provide technical leadership for formulation and process development, clinical and registration supply, technology transfer, process validation, regulatory submissions, and launch readiness.
Latigo Biotherapeutics is a biopharmaceutical company focused on developing non‑opioid therapies to relieve pain and restore health. Their approach targets the source of pain before it reaches the central nervous system, aiming to prevent chronic pain rather than merely dull symptoms. Latigo’s solutions are designed to enable healing without dependence and to provide durable relief that can help restore patients’ quality of life.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Latigobio.
Director, Drug Product
Revolution Medicines
Director, Drug Product Development
Iambic Therapeutics
Director, Drug Product Development
BioCryst Pharmaceuticals
Associate Director Drug Product SME
Madrigal Pharmaceuticals
Director, Drug Product SME
Madrigal Pharmaceuticals
Director, CMC Product Development – Small Molecule
Beeline Medicines